AMEX · Medical - Devices

MYO (MYO) Stock

$1.01 +4.12% AMEX: MYO Healthcare

Valuation

MetricValue
Price$1.01
Market Cap$39.03M
P/E Ratio-5.45
P/B Ratio5.92
P/S Ratio1.29
EPS (TTM)$-0.26
52-Week High$2.42
52-Week Low$0.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-98.53%
ROA-22.61%
ROCE-116.67%
Gross Margin65.96%
Operating Margin-34.07%
Net Margin-36.69%
Debt/Equity2.11
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$14.0M$16.0M$19.0M$33.0M$41.0M
Operating Profit$-10.0M$-11.0M$-8.0M$-6.0M$-14.0M
Net Profit$-10.0M$-11.0M$-8.0M$-6.0M$-16.0M
EPS$-1.78$-1.52$-0.28$-0.16$-0.37
Op Margin-74.1%-68.6%-42.8%-19.1%-35.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$10.0M$15.0M$42.0M$39.0M
Total Liabilities$5.0M$4.0M$6.0M$18.0M$27.0M
Cash$16.0M$5.0M$7.0M$24.0M$14.0M
Borrowings$1.0M$1.0M$1.0M$8.0M$19.0M

Latest News

iAccess Alpha Virtual Best Ideas Summer Investment Conference Begins Today ACCESS Newswire · Jun 23, 2026 iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026 ACCESS Newswire · Jun 18, 2026 Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference Business Wire · Jun 16, 2026 Undervalued Penny Stocks To Consider In June 2026 Simply Wall St. · Jun 8, 2026 Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock Zacks · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-10.0M$-6.0M$-3.0M$-15.0M
Investing Cash Flow$-1.0M$0$-2.0M$-1.0M$-9.0M
Financing Cash Flow$12.0M$0$0$1.0M$0
Net Cash Flow$3.0M$-10.0M$2.0M$18.0M$-10.0M
Free Cash Flow$-10.0M$-10.0M$-6.0M$-5.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-3.66
FCF Yield-32.52%
Quick Ratio2.36
Interest Coverage-14.00
Return 1Y-44.00%
Return 3Y40.00%
Return 5Y-86.93%

Ownership

Insiders Held9.10%
Institutions Held40.62%
Institutions Float Held44.69%
Institutional HolderSharesReport Date
Rosalind Advisors, Inc.3,847,2722026-03-31
Blackrock Inc.1,688,3902026-03-31
Vanguard Capital Management LLC1,144,3242026-03-31
Geode Capital Management, LLC858,7992026-03-31
Jefferies Financial Group Inc.704,2752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About MYO

MYO is led by CEO Paul R. Gudonis, employs 184 people, headquartered in US, publicly traded since 2017.

MYO stock trades at $1.01 with a market capitalization of $39.03M. The stock is valued at a price-to-earnings (P/E) ratio of -5.45, price-to-book of 5.92, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $0.60 and $2.42, and currently trades 58.3% below its 52-week high.

On profitability, MYO generates a return on equity (ROE) of -98.53%, return on capital employed of -116.67%, an operating margin of -34.07%, a net profit margin of -36.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides